Lijing Chen Selected Research

Glutaminase

4/2014

Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lijing Chen Research Topics

Disease

2	Neoplasms (Cancer) 12/2023 - 04/2014
1	Anxiety Disorders (Anxiety Disorder) 01/2024
1	Diabetic Nephropathies (Diabetic Nephropathy) 04/2022
1	Inflammation (Inflammations) 04/2022
1	Spinal Cord Diseases 01/2021
1	Breast Neoplasms (Breast Cancer) 04/2014
1	Triple Negative Breast Neoplasms 04/2014
1	Proteinuria 01/2011

Drug/Important Bio-Agent (IBA)

1	Anti-Anxiety Agents (Anxiolytics)IBA 01/2024
1	Adenosine (Adenocard)FDA LinkGeneric 12/2023
1	Adenosine Monophosphate (AMP)IBA 12/2023
1	Caspase 3 (Caspase-3)IBA 04/2022
1	Diosmin (Daflon)IBA 04/2022
1	Endoplasmic Reticulum Chaperone BiPIBA 04/2022
1	Glutamine (L-Glutamine)FDA Link 04/2014
1	GlutaminaseIBA 04/2014
1	CB-839IBA 04/2014
1	Glutathione (Reduced Glutathione)IBA 04/2014
1	Proteins (Proteins, Gene)FDA Link 04/2014
1	Glutamic Acid (Glutamate)FDA Link 04/2014
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2011
1	nephrinIBA 01/2011

Therapy/Procedure

1	Immunotherapy 12/2023
1	Oral Administration 12/2023
1	Laminoplasty 01/2021